ASHPOfficial

Pharmacists can be essential in managing myasthenia gravis by providing education, identifying exacerbating medications, offering therapeutic alternatives, and supporting overall appropriate pharmacotherapy. This podcast provides pharmacists with an understanding of the pathophysiology of myasthenia gravis and myasthenic crisis, common complications associated with the disease state, and useful medication management considerations for the emergency department setting. CE for this episode expires on December 20, 2027.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Discover the essential contributions of pharmacists in patient care with We're Your Pharmacist, a monthly podcast from ASHP. This episode features Jennifer Slaughter, ambulatory pharmacy supervisor at SSM Health Dean Medical Group, and her patient Debbie. Jennifer shares what inspired her to pursue a career in pharmacy and discusses the many paths within the profession, while Debbie offers her perspective as a patient and shares insights on the value of the pharmacist–patient relationship.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

A highlight from exceptional sessions at the 2025 Midyear Clinical Meeting & Exhibition, this episode discusses how pharmacists can leverage data, design optimized workflows, and demonstrate financial impact to lead population health initiatives in value-based care models. Listeners will gain practical tools for translating dashboards into interventions, building scalable workflows, and quantifying return on investment to support FTE justification and contract alignment. This conversation offers real-world examples and takeaways to help pharmacists position themselves as indispensable players in team-based care. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

A highlight from exceptional sessions at the 2025 Midyear Clinical Meeting & Exhibition, this episode describes the importance of preparation and professionalism throughout the interview process. Listeners can expect to learn tips and tricks for preparing for residency interviews.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Join us for a special podcast series spotlighting student member experiences at 2025 Midyear Clinical Meeting & Exhibition in Las Vegas, NV. Hear perspectives from attendees as they seize opportunities to network, learn and attend residency showcase and PPS. Hear firsthand why Midyear is the place to be – there is nothing like it! The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

A highlight from Exceptional Sessions at the 2025 Midyear Clinical Meeting & Exhibition, this episode discusses agencies and organizations other than USP that impact how we handle Compounded Sterile Preparations. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast, Dr. Anna Dopp and Mr. Tom Kraus discuss the AJHP Editorial "An advocacy roadmap to recognition and payment for pharmacist patient-care services” with host and AJHP Editor in Chief Dr. Daniel Cobaugh. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Anaphylaxis is an acute, life-threatening allergic reaction with an estimated prevalence of approximately 2% in the United States. Prompt recognition of anaphylaxis is necessary for appropriate treatment. This episode will review pathophysiology, clinical presentation and management of anaphylaxis. CE for this episode expires on December 13, 2027.   The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Join us for a special podcast series spotlighting student member experiences at 2025 Midyear Clinical Meeting & Exhibition in Las Vegas, NV. Hear perspectives from attendees as they seize opportunities to network, learn and attend residency showcase and PPS. Hear firsthand why Midyear is the place to be – there is nothing like it! The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Join us for a special podcast series spotlighting student member experiences at 2025 Midyear Clinical Meeting & Exhibition in Las Vegas, NV. Hear perspectives from attendees as they seize opportunities to network, learn and attend residency showcase and PPS. Hear firsthand why Midyear is the place to be – there is nothing like it!    The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Unhealthy substance use and substance use disorders remain major public health challenges in the United States. As evidence supporting medications for opioid use disorder continues to grow, pharmacists are playing an increasingly important role in managing substance use disorders, particularly by bridging primary care gaps in rural communities and healthcare deserts. This podcast explores how pharmacists are expanding access to care, leveraging telemedicine, collaborating across healthcare teams, and improving public health outcomes. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This episode discusses the current guidelines for the treatment of adult cardiopulmonary arrest, reviews evidence-based algorithms aimed at improving outcomes of survival and discusses the role of pharmacologic therapies recommended for pulseless rhythms.  CE for this episode expires on November 29, 2027.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Join ASHP President, Melanie Dodd, and Vice President of Accreditation Services, Sam Calabrese, as they walk through ASHP's newly updated strategic plan. Speakers share the story behind the plan's development, including how member feedback played a pivotal role in shaping its direction to reflect the needs and aspirations of the pharmacy profession. Speakers highlight the five strategic pillars that form the foundation of the plan and discuss how ASHP is already putting these priorities into action.   The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Discover the essential contributions of pharmacists in patient care with We're Your Pharmacist, a monthly podcast from ASHP. This episode features a panel of pharmacists across a variety of practice areas across the country. They share what inspired them to pursue a career in pharmacy and offers insights into the many paths within the profession, highlighting how pharmacists make a difference every day.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

The Centers for Disease Control and Prevention recently released its Core Elements of Hospital Diagnostic Excellence. Given the significant implications of diagnostic stewardship on the use of antimicrobials, US Antibiotic Awareness Week is an excellent opportunity to begin to unpack this topic. This podcast reviews the core elements and explores the opportunities for pharmacists to engage in diagnostic stewardship and how this topic has broader implications beyond antimicrobial use.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Spark Brilliance is the theme for the 2025 ASHP Midyear Clinical Meeting & Exhibition and there's no better place to ignite your clinical pharmacy leadership journey. Join experienced conference attendees and featured speakers as they share insights on leadership, clinical innovation, and professional growth while highlighting everything Midyear has to offer! The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

ASHP's senior education director, Cindy Von Heeringen is joined by William Dager, pharmacist specialist (Ret.) at University of California, Davis Medical Center, as he discusses his upcoming Midyear session that focuses on anticoagulation management plans in complex patients. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This episode guides pharmacists through the essentials of pediatric primary and secondary survey assessment, common etiologies of pediatric cardiopulmonary arrest, pediatric advanced life support algorithms for dysrythmias, and provide useful medication tips and management considerations for the clinical pharmacist. CE for this episode expires on November 15, 2027.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This episode explores why ASHP's Council on Public Policy has taken a fresh approach to a longstanding question: how should pharmacists be reimbursed for cognitive services? Joining the conversation are the council's secretary and a former member who is also a health-system leader. They break down the newly adopted Policy 2506, Payment Parity for Pharmacists' Services, discuss what it aims to accomplish for practicing pharmacists, and examine the broader implications if progress is achieved. The episode unpacks why policy language matters, traces the evolution of ASHP's stance on pharmacist payment parity, and explores how the new policy could help advance this critical issue. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In celebration of Veterans Day, this episode highlights three ASHP members who volunteered to join the military in service to our Nation. Lieutenant Colonel Sherry Kwon, U.S. Army speaks with Navy veteran Tim Lynch, Air Force veteran Nancy Nystrom, and Army veteran Dale English about their stories, reflections, and perspectives on how their military experience helped shape their careers, lives, and their sense of paying it forward to provide an inspiration for others.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast will provide members with an update on federal and state action over the past 6 months on the 340B program. We'll talk through 340B policy shifts at the federal level and what's happening in the states. We'll also discuss where 340B advocacy goes from here.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Ever wondered how pharmacy technicians can shape the future of pharmacy regulation? Listen as pharmacy technicians share their experiences serving on State Boards of Pharmacy and learn how you can advocate for technician representation in your state.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

ASHP's Education Director, Hannah Post, is joined by Kristin Zimmerman, Associate Professor at Virginia Commonwealth University Health, to discuss an upcoming Midyear session presented by Marina Trefethen, PharmD, BCPP, Mental Health Clinical Pharmacist Practitioner at the White River Junction Department of Veterans Affairs Healthcare System. The session explores GLP-1 receptor agonist effects on substance use and addictive behaviors in both clinical trials and real-world populations. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

ASHP co-hosted an invitational summit with APhA and NABP in June 2025 to discuss workplace and well-being issues in the pharmacy workforce. In this episode, two attendees reflect on the experience and the actions of their organizations to improve the pharmacy workplace and discuss the newly released report on the 2025 Implementing Solutions summit. Learn about the new workforce summit report and actionable solutions for well-being that can implemented within an organization. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This episode discusses the evolving standards of care in providing support after rapid sequence intubation (RSI) and highlights RSI pharmacology and the management of post-intubation analgesia and sedation. CE for this episode expires on November 1, 2027.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Discover the essential contributions of pharmacists in patient care with We're Your Pharmacist, a monthly podcast from ASHP. This episode features Amber Lanae Martirosov, associate clinical professor of pharmacy practice at Wayne State University and clinical specialist at Henry Ford Hospital. She shares what inspired her to pursue a career in pharmacy and offers insights into the many paths within the profession, highlighting how pharmacists make a difference every day.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode, current and past executive committee members for the Section of Specialty Pharmacy Practitioners sit down together to share stories and discuss the impact made by the 2024 Distinguished Service Awardee, Tara Kelley.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode, student leaders from Rutgers University share how their SSHP developed the NxtGen Student Leadership Program—a peer-led initiative focused on building leadership skills and preparing future pharmacy leaders. Listeners will hear how the program was designed, how it engages members at all levels, and the impact it's had on their chapter. This episode offers practical takeaways for other SSHPs interested in starting or strengthening their own leadership development programs.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Join members of the Council on Pharmacy Practice to unpack ASHP's newly approved policy on moral distress and moral injury. They'll explain what these terms mean, share real-world examples, and explore how moral injury contributes to occupational burnout in the pharmacy workforce. The conversation takes you behind the scenes of the policy process, highlighting challenges faced along the way, and look ahead to what this policy means for the future of pharmacy practice. Listeners will be introduced to the emerging concepts of moral distress and moral injury and discover how they impact the pharmacy profession. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

ASHP's education director, Hannah Post, is joined by Curtis Geier, emergency medicine clinical pharmacist at San Francisco General Hospital, as he discusses his upcoming Midyear sessions that focus on the role of pharmacists in the care of patients in cardiac arrest.   The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Pharmacists providing rapid sequence intubation (RSI) care are faced with evolving standards of care in special patient populations. This episode features RSI pharmacology in special patient populations, including myasthenia gravis, pregnancy and obesity. CE for this episode expires on October 18, 2027.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Collaborative practice agreements (CPAs) are formal agreements between pharmacists and other healthcare providers that allow pharmacists to perform specific tasks independently at the top of their license. CPAs are a powerful tool widely used in the outpatient setting but not used as frequently in the inpatient setting. This episode discusses the considerations for developing and implementing a successful inpatient CPA and the benefits to patient care quality, safety, and efficiency. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast, Dr. Dusty Linn discusses the AJHP Clinical Consultation "Strategies to prevent awareness with paralysis following administration of neuromuscular blocking agents” with host and AJHP Editor in Chief Dr. Daniel Cobaugh. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

ASHP's senior education director Cindy Von Heeringen is joined by Lisa Janssen Carlson, IDS manager, and Craig Michael, data science pharmacist, both from the University of California, San Francisco as they discuss their upcoming Midyear session that focuses on incorporating AI in current pharmacy practice settings to enhance or streamline workflows.   The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Members of the Council on Therapeutics unpack two ASHP policies adopted in the 2025 House of Delegates— one addressing the FDA's proposal to change drug naming conventions, and the other requiring height and weight on certain medication orders. They share why these policies matter, the challenges encountered during the policy process, and the improvements they hope to see in patient care as a result. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This session focuses on various pharmacogenomics implementation models in oncology. Presenters discuss how pharmacogenomics was implemented at their respective institution, how each addressed unique barriers to implementation, and considerations for scalability, sustainability, and expansion of pharmacogenomics testing in oncology over the next 5+ years. CE for this episode expires two years after publication. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode, the team from The Ohio State University Wexner Medical Center discusses their award-winning ASHP Best Practices submission.  They share how the program leveraged the unique expertise of pharmacist informaticists to take advantage of  EHR and build tools to automate the selection of preferred biosimilar, iron and Biosimilars, Iron, and 505(b)(2)  products based on the patient's insurance and hospital formulary preferences and time to payor approval for patients, reduced the administrative burden of the PA process, and improved the quality of our patient care. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

ASHP's education director, Hannah Post is joined by Angela Cassano, president of Pharmfusion Consulting, LLC, William Hammonds, clinical pharmacy manager at West Virginia University Medicine, and Carrington Huneycutt, director of clinical pharmacy at Tandem Health, South Carolina, as they discuss their upcoming Midyear session that focuses on implementation and evolution of clinical pharmacy technician roles.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Pharmacists providing care to patients following toxicologic ingestions of medications and other substances are often relied upon for treatment and monitoring recommendations. Many pharmacists do not routinely care for patients following toxicologic ingestions of medications or other substances and are unfamiliar with clinical presentation of various toxidromes and ultimately management strategies. This episode covers anticholinergic, cholinergic, sedative-hypnotic, opioid, sympathomimetic, serotonin syndrome, neuroleptic malignant syndrome, and malignant hypethermia toxidromes and discusses the clinical presentation and causative medications/substances and general treatment approaches, with an emphasis on antidotes for specific toxidromes including physostigmine, naloxone, flumazenil, atropine, and pralidoxime. CE expires two years from when this episode was originally published. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode, we dive into the essentials of beyond-use dating (BUD) in sterile compounding. What exactly is a BUD, and how does it differ from a manufacturer's expiration date? We'll break it down, explore key insights from USP , and highlight what every sterile compounder needs to know.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Discover the essential contributions of pharmacists in patient care with We're Your Pharmacist, a monthly podcast from ASHP. This episode features Charrai Byrd, director of pharmacy services at New York-Presbyterian Hospital, as he shares what drew him to a career in pharmacy. Gain insights into the diverse opportunities within the pharmacy profession and learn how pharmacists are making a difference every day.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast explores unique opportunities for pharmacists to pursue a Fulbright Scholar Award, highlighting pathways for academic exchange, research, and global health collaboration. Featuring insights from a recent Fulbright recipient, the discussion covers how pharmacists can contribute to and benefit from international scholarship and cultural diplomacy.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

ASHP's senior education director, Cindy Von Heeringen is joined by James Hoffman, senior vice president of quality and safety, member, pharmacy and pharmaceutical sciences at St. Jude Children's Research Hospital, and Joe DiPiro, professor emeritus at Virginia Commonwealth University, School of Pharmacy, as they discuss their upcoming Midyear session that focuses on relevant trends in the external environment that will have a major impact on health-system pharmacy practice over the next five years.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This episode discusses the remainder of the results of the work from home survey conducted in 2024 by members of the Section of Specialty Pharmacy Practitioners Advisory Group on Operational and Workforce Development. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast provides a review of newer over-the-counter (OTC) items related to pharmacy practice. Participants discuss OTC CGMs, naloxone, birth control, combined influenza/COVID home tests and STD/syphilis home tests. The episode highlights cost information, where to purchase, how and when to use, and more. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

ASHP's senior education director, Cindy Von Heeringen is joined by Tyler Vest, network director of pharmacy, pharmacy supply chain at the University of Vermont Health Network, as he discusses his upcoming Midyear sessions that focus on ongoing research about the medication use process and the current state.   The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast, members of the Pharmacy Administration and Leadership Residents' Collaborative explore disruptive innovations with Dr. Nishaminy Kasbekar and consider future implications as we work to expand medication access. Speakers discuss how these changes are transforming drug procurement, addressing challenges like drug shortages, and improving medication affordability for patients. Dr. Kasbekar also shares insights on how models like those adopted at her own institution could shape the future of pharmacy practice across health systems nationwide.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

ASHP's senior education director, Cindy von Heeringen is joined by Mitchell Buckley, clinical pharmacy specialist at Buckley Group Enterprises LLC, as he discusses his upcoming Midyear sessions that focus on acute care clinical pharmacy performance metrics and the unique pharmacokinetic and pharmacodynamic challenges in dosing chemotherapy, anticoagulants, and antimicrobials for obese and underweight patients.   The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In anticipation of the 2025 ASHP Conference for Pharmacy Leaders, ASHP is hosting a series of podcast episodes. Join our host, Cynthia Von Heeringen, senior education director at ASHP, as she interviews John Clark, associate chief pharmacy officer at Michigan Medicine Health and clinical associate professor at the University of Michigan College of Pharmacy, and Tara Vlasimsky, system director of ambulatory pharmacy for Intermountain Health, as they discuss their upcoming session From Strategy to Execution for Agile Organizations.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Join us for a conversation with Cheryl Wisseh and Ryan Larson, ASHP Foundation grantees, who will discuss their research, implications for practice, and improving the health of patients and communities.   The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

The American Foundation for Suicide Prevention (AFSP) is a voluntary health organization that gives those affected by suicide a nationwide community empowered by research, education, and advocacy to take action against this leading cause of death. With local programs and events in all 50 states, AFSP's chapters are at the forefront of suicide prevention. This podcast will highlight the impact of change, specifically major life transitions, on mental health and suicide risk, as well as how members can address these challenges to promote positive well-being.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.